サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387444

デメロール/メペルジン市場レポート：2030年までの動向、予測、競合分析

Demerol Meperdine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

デメロール/メペルジン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

デメロール/メペルジンの動向と予測

世界のデメロール/メペルジン市場は、2024年から2030年までのCAGRが3.1％で、2030年までに推定4億米ドルに達すると予測されます。この市場の主な促進要因は、ドラッグデリバリーシステムの進歩と相まって、市販鎮痛薬の費用対効果が高いこと、患者の意識が高まっていること、効果的な疼痛管理ソリューションが入手可能であることです。デメロール/メペルジンの世界市場は、鎮痛、麻酔、咳止め、下痢止め、脱中毒の各市場における機会により、将来が有望視されています。

デメロール/メペルジン市場の洞察

Lucintelの予測では、急性痛や激痛の治療に役立つことから、予測期間中は非経口薬が引き続き大きなセグメントを占める。

この市場の中では、急性および慢性の疼痛性疾患の発生により、鎮痛剤が最も高い成長を遂げると予測されます。

北米は、旺盛なヘルスケア支出と慢性疼痛への対応ニーズの高まりから、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のデメロール/メペルジン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のデメロール/メペルジン市場動向（2018-2023）と予測（2024-2030）
  • 製品タイプ別の世界のデメロール/メペルジン市場
    • 非経口
    • 錠剤
  • 用途別の世界のデメロール/メペルジン市場
    • 鎮痛剤
    • 麻酔
    • 咳止め
    • 下痢の抑制
    • 脱依存症

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のデメロール/メペルジン市場
  • 北米のデメロール/メペルジン市場
  • 欧州のデメロール/メペルジン市場
  • アジア太平洋のデメロール/メペルジン市場
  • その他地域のデメロール/メペルジン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界のデメロール/メペルジン市場の成長機会
    • 用途別の世界のデメロール/メペルジン市場の成長機会
    • 地域別の世界のデメロール/メペルジン市場の成長機会
  • 世界のデメロール/メペルジン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のデメロール/メペルジン市場の能力拡大
    • 世界のデメロール/メペルジン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Actavis
  • Sun Pharmaceuticals
  • Sanofi
  • Boehringer Ingelheim
  • Pfizer
  • Janssen Pharmaceuticals
  • Egalet Corporation
目次

Demerol Meperdine Trends and Forecast

The future of the global demerol meperdine market looks promising with opportunities in the pain relief, anesthesia, cough suppression, and diarrhea suppression and de-addiction markets. The global demerol meperdine market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are cost-effectiveness of over-the-counter (otc) analgesic drugs, coupled with advancements in drug delivery systems, rising patient awareness, and availability of effective pain management solutions.

A more than 150-page report is developed to help in your business decisions.

Demerol Meperdine by Segment

The study includes a forecast for the global demerol meperdine by product type, application, and region.

Demerol Meperdine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Parenteral
  • Tablets

Demerol Meperdine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pain Relief
  • Anesthesia
  • Cough Suppression
  • Diarrhea Suppression
  • De-Addiction

Demerol Meperdine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Demerol Meperdine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies demerol meperdine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the demerol meperdine companies profiled in this report include-

  • Actavis
  • Sun Pharmaceuticals
  • Sanofi
  • Boehringer Ingelheim
  • Pfizer
  • Janssen Pharmaceuticals
  • Egalet Corporation

Demerol Meperdine Market Insights

Lucintel forecasts that parenteral will remain the larger segment over the forecast period as it helps in treating acute and severe pain.

Within this market, pain relief is expected to witness the highest growth due to occurence of acute and chronic painful disorders.

North America will remain the largest region over the forecast period due to strong healthcare expenditure and rising need to deal with chronic pain in the region.

Features of the Global Demerol Meperdine Market

Market Size Estimates: Demerol meperdine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Demerol meperdine market size by product type, application, and region in terms of value ($B).

Regional Analysis: Demerol meperdine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the demerol meperdine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the demerol meperdine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the demerol meperdine market size?

Answer: The global demerol meperdine market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for demerol meperdine market?

Answer: The global demerol meperdine market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the demerol meperdine market?

Answer: The major drivers for this market are cost-effectiveness of over-the-counter (otc) analgesic drugs, coupled with advancements in drug delivery systems, rising patient awareness and availability of effective pain management solutions.

Q4. What are the major segments for demerol meperdine market?

Answer: The future of the demerol meperdine market looks promising with opportunities in the pain relief, anesthesia, cough suppression, and diarrhea suppression and de-addiction markets.

Q5. Who are the key demerol meperdine market companies?

Answer: Some of the key demerol meperdine companies are as follows:

  • Actavis
  • Sun Pharmaceuticals
  • Sanofi
  • Boehringer Ingelheim
  • Pfizer
  • Janssen Pharmaceuticals
  • Egalet Corporation

Q6. Which demerol meperdine market segment will be the largest in future?

Answer: Lucintel forecasts that parenteral will remain the larger segment over the forecast period as it helps in treating acute and severe pain.

Q7. In demerol meperdine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to strong healthcare expenditure and rising need to deal with chronic pain in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the demerol meperdine market by product type (parenteral and tablets), application (pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Demerol Meperdine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Demerol Meperdine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Demerol Meperdine Market by Product Type
    • 3.3.1: Parenteral
    • 3.3.2: Tablets
  • 3.4: Global Demerol Meperdine Market by Application
    • 3.4.1: Pain Relief
    • 3.4.2: Anesthesia
    • 3.4.3: Cough Suppression
    • 3.4.4: Diarrhea Suppression
    • 3.4.5: De-addiction

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Demerol Meperdine Market by Region
  • 4.2: North American Demerol Meperdine Market
    • 4.2.2: North American Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
  • 4.3: European Demerol Meperdine Market
    • 4.3.1: European Demerol Meperdine Market by Product Type: Parenteral and Tablets
    • 4.3.2: European Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
  • 4.4: APAC Demerol Meperdine Market
    • 4.4.1: APAC Demerol Meperdine Market by Product Type: Parenteral and Tablets
    • 4.4.2: APAC Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
  • 4.5: ROW Demerol Meperdine Market
    • 4.5.1: ROW Demerol Meperdine Market by Product Type: Parenteral and Tablets
    • 4.5.2: ROW Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Demerol Meperdine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Demerol Meperdine Market by Application
    • 6.1.3: Growth Opportunities for the Global Demerol Meperdine Market by Region
  • 6.2: Emerging Trends in the Global Demerol Meperdine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Demerol Meperdine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Demerol Meperdine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Actavis
  • 7.2: Sun Pharmaceuticals
  • 7.3: Sanofi
  • 7.4: Boehringer Ingelheim
  • 7.5: Pfizer
  • 7.6: Janssen Pharmaceuticals
  • 7.7: Egalet Corporation